CellType is a startup based in the United States, most recent round Seed.
CellType is a company headquartered in the United States. Its most recent tracked round is Seed.
CellType develops AI agents that run the full drug discovery pipeline using biological foundation models that simulate human biology. Their technology, developed with Google DeepMind, has identified and validated a new cancer treatment signal and they are working with top 10 pharmaceutical companies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.